PEA15 antisense RNA 1 (PEA15-AS1)

PEA15 antisense RNA 1 (PEA15-AS1) is a long non-coding RNA (lncRNA) that is transcribed from the genomic region opposite the PEA15 protein-coding gene[3]. While the precise biological functions, disease associations, and mechanisms of action of PEA15-AS1 have not been well-characterized in the current scientific literature, lncRNAs of this type can act as regulators of their sense partner genes (in this case, PEA15), or participate in wider regulatory networks. There is no evidence that PEA15-AS1 encodes a receptor, enzyme, or other canonical druggable target, nor are specific drugs or biomarkers associated with it. Some lncRNAs are emerging as modulators or biomarkers in cancer and other diseases, so possible disease relevance cannot be excluded, but there is no direct, well-documented implication for PEA15-AS1 at this time[3]. Key points: - PEA15-AS1 is not a protein, receptor, or a typical therapeutic target; it is an RNA gene. - Most available literature and databases only confirm its identity as an lncRNA, and do not attribute typical target roles or druggability[3]. - Scientific understanding of PEA15-AS1's function in disease is incomplete; its putative significance would be indirect or regulatory in nature. - There is no evidence for direct drug interactions, associated mechanisms of action, or safety considerations specific to PEA15-AS1. If a canonical drug target is required, the nearby PEA15 gene codes for a protein implicated in cancer and cell signaling, but that is distinct from PEA15-AS1[1][2][4].

Other names

PEA15-AS1PEA15 antisense RNA 1